BioInfoBank focuses on making lab products profitable

"We specialize in biological, medical and IT sectors. Our services are often used by companies looking for new pharmaceutical products. We assess the viability of chemical compounds used in drugs. There are several million of them on the market, but only a few are further processed," said Leszek Rychlewski, founder of BioInfoBank. The company is not set on multiplying its profits, but rather focuses on promoting and commercializing technologies, which are prepared in research units. "Scientists need capital and some courage. BioInfoBank Seed Capital will provide both," said Rychlewski. The fund has so far invested zł.300,000 in five start-up companies. The first such fund is training field testing the capacity of the domestic market. "We would like to set up another fund and receive subsidies from the Polish Agency for Entrepreneurship Development (PARP). The agency will have at its disposal tens of million of Euro from EU structural funds dedicated for subsidizing investment funds," said Rychlewski. (Puls Biznesu, pp. 1, 5) M.M.